2022
DOI: 10.1038/s41556-022-00842-x
|View full text |Cite
|
Sign up to set email alerts
|

Telomere dysfunction in ageing and age-related diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
238
2
5

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 364 publications
(251 citation statements)
references
References 210 publications
(255 reference statements)
6
238
2
5
Order By: Relevance
“…The classical TBD is dyskeratosis congenita (DC), which presents with mucocutaneous triad of reticular skin pigmentation, nail dysplasia, and oral leukoplakia, and is predominantly a pediatric disease. TBDs, especially in adults, have a broad phenotypic variability and can present with hematological (cytopenias), pulmonary (idiopathic pulmonary fibrosis), gastrointestinal (cirrhosis), or immunodeficiency phenotypes, and present with a variable constellation of symptoms, penetrance, inheritance, and age of onsets (genetic anticipation) [ 3 , 4 ]. Currently, the clinical approach to identify TBD patients includes telomere length measurement by flowFISH and/or identification of a pathogenic variant in one of the genes affecting telomere structural integrity and maintenance specifically, DKC1 , TERC , TERT , NOP10 , NHP2 , ACD , TINF2 , POT1 , CTC1 , STN1 , WRAP53 , RTEL1 , PARN , NAF1 , and ZCCHC8 [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The classical TBD is dyskeratosis congenita (DC), which presents with mucocutaneous triad of reticular skin pigmentation, nail dysplasia, and oral leukoplakia, and is predominantly a pediatric disease. TBDs, especially in adults, have a broad phenotypic variability and can present with hematological (cytopenias), pulmonary (idiopathic pulmonary fibrosis), gastrointestinal (cirrhosis), or immunodeficiency phenotypes, and present with a variable constellation of symptoms, penetrance, inheritance, and age of onsets (genetic anticipation) [ 3 , 4 ]. Currently, the clinical approach to identify TBD patients includes telomere length measurement by flowFISH and/or identification of a pathogenic variant in one of the genes affecting telomere structural integrity and maintenance specifically, DKC1 , TERC , TERT , NOP10 , NHP2 , ACD , TINF2 , POT1 , CTC1 , STN1 , WRAP53 , RTEL1 , PARN , NAF1 , and ZCCHC8 [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The key finding from our study that a small, nondistorting oxidative base lesion within telomeres is sufficient to induce premature senescence in the absence of telomere shortening is surprising, but provides a mechanistic explanation for telomere dysfunction foci arising in vivo in various contexts 27 . Mouse cardiomyocytes and baboon hepatocytes in vivo, show increased DDR+ telomeres with age, with no appreciable shortening despite the presence of senescence markers 20 , 76 .…”
Section: Discussionmentioning
confidence: 69%
“…Dysfunctional telomeres are recognized by γH2AX and 53BP1 localization at telomeres, which are downstream effectors of DDR kinases ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3‑related) 25 , 26 . These foci are called TIFs (telomere dysfunction induced foci), TAFs (telomere associated DDR foci), or DDR+ telomeres 27 . Whereas telomere deprotection upon shelterin disruption activates the DDR 26 , evidence is lacking that ROS-induced telomere damage is extensive enough to completely displace shelterin.…”
Section: Mainmentioning
confidence: 99%
“…Conversely, switch genes obtained from subjects engaged in high physical activity were predominantly associated with DNA repair mechanisms and telomerase maintenance. Telomerase maintenance positively influences longevity [ 20 ], and telomeric dysfunction is associated with developing a wide range of diseases, including cancer, metabolic disorders, and neurodegeneration [ 21 ]. Increased DNA double-strand breaks and altered levels of DNA repair proteins have been reported in the hippocampus of AD subjects [ 22 ] and neuronal and glial cells in the early stages of the disease [ 23 ].…”
Section: Discussionmentioning
confidence: 99%